Home › Master Spec › Medical & Regenerative Medicine Facilities
IPLS Foundation Release v0.5.4 • 11 May 2026 • 100 % Lighthouse Scores (Mobile + Desktop) • Disciplined Requirements Engineering • External Validation Integrated • Foundation Phase 100 % Complete
NOW OPEN Serious contributors wanted — Section 7.1 Contributor Value Proposition is live Read what you receive →
Lane B Engineering extrapolation (known physics, plausible scaling)

Medical & Regenerative Medicine Facilities

Advanced healthcare infrastructure for hollowed-asteroid bases — designed to keep multi-century crews healthy, treat injuries, and fully leverage future ASI breakthroughs in regenerative medicine and aging reversal.

Purpose

Provide on-site medical capability that matches or exceeds Earth standards while being completely self-sufficient for centuries. The facility must handle routine care, trauma, surgery, and the advanced regenerative therapies that will become available once ASI arrives.

Key Functional Requirements

  • Full diagnostic suite (imaging, genetic sequencing, real-time biomarker monitoring)
  • Operating theatres and robotic surgical systems capable of complex procedures
  • Regenerative medicine labs (stem-cell therapy, tissue engineering, organ printing)
  • Pharmacy and on-site pharmaceutical synthesis using ISRU-derived materials
  • Isolation and quarantine modules for potential unknown pathogens
  • Psychological and neurological care integration with the recreation systems
  • Whether cryogenic or stasis capability is within this section is unset.
  • Modular design using Universal Modular Platform hardpoints for easy expansion
  • Whether AI-assisted triage is within this section is unset.

Operational Integration

The medical facility is constructed after life support, power, internal transport, and recreation systems are operational. It serves both the base population and any visiting crews from the mining fleet or external vessels.

IPLS-IPLS-3.1.10-001 Maturity: B
Phase 4

On-Site Medical & Regenerative Medicine Mandate

Requirement: The facilities are those in IPLS-3.1.10-002 to 007. The sizing population is unset. Whether cryogenic or stasis capability and AI-assisted triage are within this section is unset. Power to medical hardpoints follows IPLS-3.1.6-006. Whether medical loads are life-support loads under IPLS-3.1.6-003 is unset.

Rationale: Long-duration crews require immediate, self-sufficient medical capability far from Earth, including future ASI-enabled regenerative and life-extension technologies.

Interfaces
UMP-ECLSS-001, UMP-ROBOTIC-001, PGEDS-v1, Life Support (3.1.5)
Verification Method
Medical-system integration bench test • Digital-twin emergency response simulation
Failure Modes & Mitigations
Medical capacity shortfall (mitigated by modular expansion and robotic assistance)
Dependencies
Life Support (3.1.5), Hollowed Asteroid Bases (3.1.4)

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-002 Maturity: B
Phase 4

Full Diagnostic & Surgical Suite

Requirement: Imaging modalities, sequencing capability, the procedure list, and the diagnostic accuracy threshold are unset. N+2 applies per function. N per function is unset. Whether diagnostic and surgical equipment is life-critical under IPLS-3.1.5-008 is unset. Overrides follow IPLS-3.1.10-007. Which procedures fall inside the IPLS-5.1-002 envelope is unset. Whether a procedure may act on a person without that person's consent is unset. Access to medical data and its data path are unset. Access to psychological data is unset under IPLS-3.1.9-006.

Rationale: Enables rapid diagnosis and treatment of trauma, illness, and age-related conditions in a closed environment.

Interfaces
UMP-SENSOR-001, UMP-ROBOTIC-001, Operator-Control Layer
Verification Method
Diagnostic accuracy testing • Robotic surgery validation
Failure Modes & Mitigations
Equipment failure (mitigated by N+2 redundancy and hot-swap modules)
Dependencies
IPLS-3.1.10-001

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-003 Maturity: B
Phase 4

Regenerative Medicine & Tissue Engineering Labs

Requirement: Which listed therapies are Lane B and which are Lane C is unset. Biomaterial feedstock, its source, and its specification are unset. ISRU feedstock follows IPLS-3.1-009. The 3.1.20 tier of lab robots is unset. Lab isolation follows IPLS-3.1.5-006. Whether lab air and waste are isolated from the life-support loop is unset. The sterility standard and N per lab function are unset.

Rationale: Provides on-site capability for life-extension and injury recovery, eliminating Earth dependency for long-lived crews.

Interfaces
UMP-ECLSS-001, On-Site Manufacturing (3.1.13), Robotics Tiering (3.1.20)
Verification Method
Regenerative process validation • Digital-twin lab simulation
Failure Modes & Mitigations
Biomaterial contamination (mitigated by sterile isolation protocols)
Dependencies
IPLS-3.1.10-002

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-004 Maturity: B
Phase 4

On-Site Pharmaceutical Synthesis

Requirement: The formulary, purity standard, and throughput are unset. N for synthesis trains is unset. Whether a medicines reserve independent of synthesis is held, and its size, are unset. Precursor specification and source are unset. ISRU feedstock follows IPLS-3.1-009. The 3.1.20 tier of synthesis robots is unset.

Rationale: Eliminates the need for Earth resupply of critical pharmaceuticals over multi-century missions.

Interfaces
On-Site Manufacturing (3.1.13), UMP-ROBOTIC-001
Verification Method
Synthesis accuracy and purity testing
Failure Modes & Mitigations
Production shortfall (mitigated by redundant synthesis trains)
Dependencies
IPLS-3.1.10-003

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-005 Maturity: B
Phase 4

Quarantine & Isolation Modules

Requirement: Automatic activation acts inside the IPLS-5.1-002 envelope and is logged and reported to the operator. Whether activation may confine a person without that person's consent is unset. The activation trigger, the release condition, and who may release are unset. Egress follows IPLS-3.1.8-005. How egress is reconciled with containment is unset. Seals follow UMP-SEAL-001. Power follows IPLS-3.1.6-006. Whether a quarantine loop is life-critical under IPLS-3.1.5-008 is unset. Pressure differential, air-change rate, and the containment standard are unset.

Rationale: Protects the broader base population from potential biological threats in a sealed environment.

Interfaces
UMP-SEAL-001, UMP-ECLSS-001, Life Support (3.1.5)
Verification Method
Isolation pressure and airflow testing
Failure Modes & Mitigations
Containment breach (mitigated by triple-redundant seals and negative-pressure design)
Dependencies
IPLS-3.1.10-001

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-006 Maturity: B
Phase 4

Psychological & Neurological Care Integration

Requirement: Psychological monitoring follows IPLS-3.1.9-006. Treatment follows this section. Access to psychological data is unset. Whether AI-assisted support may act on a person without that person's consent is unset. Digital minds follow IPLS-3.1.22-004. Loss of link follows IPLS-3.1.5-011.

Rationale: Mental health is as critical as physical health for multi-century crews.

Interfaces
Recreation, Entertainment, Psychological & Social Systems (3.1.9), UMP-DIAG-001
Verification Method
Integrated psychological-medical simulation
Failure Modes & Mitigations
Undetected mental health decline (mitigated by continuous multi-modal monitoring)
Dependencies
IPLS-3.1.9

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-007 Maturity: B
Phase 4

Operator Control & Manual Override in Medical Systems

Requirement: Critical medical functions shall expose physical overrides. Their use follows IPLS-3.1.4-007. On loss of link, life-preserving functions continue inside the IPLS-5.1-002 envelope and other actions follow the IPLS-3.1-014 hold. T is unset. The safe step for a procedure in progress is unset. The list of critical medical functions is unset. Whether a veto can stop a life-preserving action already running is unset. Life-support functions follow 3.1.5.

Rationale: Keeps the stop with the operator under IPLS-5.1-002.

Interfaces
UMP-OPERATOR-001
Verification Method
Human-in-the-loop medical override testing
Failure Modes & Mitigations
Automation lockout during emergency (mitigated by physical interlocks)
Dependencies
UMP-OPERATOR-001

Open Questions: None at v0.7

IPLS-IPLS-3.1.10-008 Maturity: B
Phase 4

Multi-Century Medical Durability & TSP-v1 Readiness

Requirement: Life-critical systems remain at the 500-year figure in IPLS-3.1-016. Whether medical elements are life-critical is unset. TSP-v1 readiness criteria are undefined. Supersession waits for operator consent under IPLS-5.1-002.

Rationale: Ensures the medical system remains effective as regenerative and life-extension technologies advance.

Interfaces
TSP-v1, UMP-DURABILITY-001
Verification Method
Accelerated life testing • TSP-v1 retrofit simulation
Failure Modes & Mitigations
Irreparable equipment failure (mitigated by modular design and on-site replication)
Dependencies
All prior 3.1.10 items

Open Questions: None at v0.7